Vivitrol Approved Labeling Leaves Room For Broad Marketing Plan

Naltrexone is the first FDA-approved extended-release monthly alcohol dependence drug, Alkermes and Cephalon say.

Pink Sheet Podcast

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".

More from Archive

More from Pink Sheet